Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_assertion type Assertion NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_head.
- NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_assertion description "[In vivo studies indicated that pM treatment diminished intracranial tumor growth and the immuno histochemical analysis showed decreased phospho-p65 and enhanced phospho-JNK levels that correlated with increased TUNEL-positive apoptotic cells in pM-treated tumor sections.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_provenance.
- NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_assertion evidence source_evidence_literature NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_provenance.
- NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_assertion SIO_000772 21573233 NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_provenance.
- NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_assertion wasDerivedFrom befree-20140225 NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_provenance.
- NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_assertion wasGeneratedBy ECO_0000203 NP832853.RA_mGuZ3zz5KVj1CWL9e1w3Dgt6yxYHePTTSeDL_pJkt0130_provenance.